Co-Diagnostics, Inc. (CODX) announced the date for its third quarter 2026 earnings release and investor webcast, providing a routine update on the company's molecular diagnostics platform performance.
The company announced the date for its third quarter 2026 earnings release and webcast, a routine scheduling event with no material financial impact.
Co-Diagnostics, Inc. (Nasdaq: CODX) has officially scheduled the release of its third quarter 2026 financial results. The molecular diagnostics firm will host a webcast to discuss the quarterly performance, marking a routine update for investors following the period ending September 30, 2026.
The announcement is a routine scheduling update regarding the release of the company's third quarter 2026 financial results and the accompanying investor webcast.